Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma

Blood

Volumn 100, Issue 3, 2002, Pages 961-965

  Chiriva lnternati, Maurizio ^a,b,c   Wang, Zhiqing ^a,b,c   Salati, Emanuela ^a,b,c   Bumm, Klaus ^a,b,c   Barlogie, Bart ^a,b,c   Lim, Seah H ^a,b,c,d  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Harrington Cancer Center   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; HLA ANTIGEN CLASS 1; MELPHALAN; PREDNISONE; SPERM PROTEIN 17; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL ISOLATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MONOCYTE; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0036683378     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0408     Document Type: Article

References (21)

1. Results of high dose therapy for 1000 patients with multiple myeloma: Durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
2. Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma
3. Idpulsed adherent PBMC-derived dendritic cells prime immune system in multiple myeloma
4. Idiotypic vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
5. Idiotypic vaccination in human myeloma: Generation of tumor-specific immune responses after high-dose chemotherapy
6. Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses
7. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin
8. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias
9. New paths in human cancer serology
10. Expression of testicular genes in haematological malignancies
11. Genes encoding tumor-specific antigens are expressed in human myeloma cells
12. Sperm protein 17 (Sp17) is a novel cancer-testis antigen in multiple myeloma
13. Autoimmunogenicity of the human sperm protein Sp17 in vasectomized men and identification of linear B cell epitopes
14. Sperm protein 17 is not expressed on normal leukocytes
15. Sperm protein 17 (Sp17) in multiple myeloma: Opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk
16. Proliferating dendritic cell progenitors in human blood
17. + lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer
18. Defining tumor antigens: mRNA, protein or cytotoxicity?
19. Selection for drug resistance results in resistance to Fas-mediated apoptosis
20. Mutation in the Fas antigen in patients with multiple myeloma
21. Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion